Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development

There is individual variation in the course of disease development and response to therapy of patients with chronic lymphocytic leukemia (CLL). Novel treatment options for CLL include a new generation of purine analogs, antibodies and inhibitors of specific cell signaling pathways, which typically i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogalińska, Małgorzata, Góralski, Paweł, Błoński, Jerzy Z., Robak, Paweł, Barciszewski, Jan, Koceva-Chyła, Aneta, Piekarski, Henryk, Robak, Tadeusz, Kilianska, Zofia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403444/
https://www.ncbi.nlm.nih.gov/pubmed/28454364
http://dx.doi.org/10.3892/ol.2017.5725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403444/
https://www.ncbi.nlm.nih.gov/pubmed/28454364
http://dx.doi.org/10.3892/ol.2017.5725

Ejemplares similares